Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.52 |
| ▸ | MAOA | P21397 | 1/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.52 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.52 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.52 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.50 |
| ▸ | ANPEP | P15144 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | ALPI | P09923 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | XIAP | P98170 | 1/20 | 0.46 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6563096 | 0.95 | EPHX1 (0.56) | EPHX1TAAR1SLC6A2CYP2A6MAOA | |
| SCHEMBL1677656 | 0.87 | SLC6A2 (0.55) | EPHX1TAAR1SLC6A2CYP2A6MAOA | |
| SCHEMBL29822049 | 0.86 | TRPA1 (0.50) | EPHX1TAAR1SLC6A2CYP2A6MAOA | |
| SCHEMBL353179 | 0.86 | TRPA1 (0.50) | EPHX1TAAR1SLC6A2CYP2A6MAOA | |
| SCHEMBL5689338 | 0.86 | TRPA1 (0.50) | EPHX1TAAR1SLC6A2CYP2A6MAOA | |
| SCHEMBL4588322 | 0.86 | TAAR1 (0.50) | EPHX1TAAR1SLC6A2CYP2A6MAOA | |
| SCHEMBL11517810 | 0.86 | EPHX1 (0.48) | EPHX1TAAR1SLC6A2CYP2A6MAOA | |
| SCHEMBL353629 | 0.86 | EPHX1 (0.48) | EPHX1TAAR1SLC6A2CYP2A6MAOA | |
| SCHEMBL2604897 | 0.86 | TAAR1 (0.50) | EPHX1TAAR1SLC6A2CYP2A6MAOA | |
| SCHEMBL4981467 | 0.83 | EPHX1 (0.60) | EPHX1TAAR1SLC6A2CYP2A6MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4352449-B1 | PROJECTILE PAYLOAD FOR TRAINING AMMUNITION WITH MULTI-SPECTRAL OUTPUT | CYALUME TECH INC (US) | 2025-05-07 | — | — | EP | claimed |
| EP-4352449-A2 | PROJECTILE PAYLOAD FOR TRAINING AMMUNITION WITH MULTI-SPECTRAL OUTPUT | Cyalume Technologies, Inc (US) | 2024-04-17 | — | — | EP | claimed |
| US-11940253-B2 | Projectile payload for training ammunition with multi-spectral output | CYALUME TECHNOLOGIES, INC. (US) | 2024-03-26 | — | — | US | claimed |
| EP-4288476-A1 | HFCO-CONTAINING ISOCYANATE-REACTIVE COMPOSITIONS, POLYURETHANE FOAMS FORMED THEREFROM, AND COMPOSITE ARTICLES THAT INCLUDE SUCH FOAMS | Covestro LLC (US) | 2023-12-13 | — | — | EP | claimed |
| WO-2023140886-A2 | PROJECTILE PAYLOAD FOR TRAINING AMMUNITION WITH MULTI-SPECTRAL OUTPUT | CYALUME TECHNOLOGIES, INC. (US) | 2023-07-27 | — | — | WO | claimed |
| US-20230194226-A1 | Projectile payload for training ammunition with multi-spectral output | PNC BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT | 2023-06-22 | — | — | US | claimed |
| WO-2022169578-A1 | HFCO-CONTAINING ISOCYANATE-REACTIVE COMPOSITIONS, POLYURETHANE FOAMS FORMED THEREFROM, AND COMPOSITE ARTICLES THAT INCLUDE SUCH FOAMS | COVESTRO LLC (US) | 2022-08-11 | — | — | WO | claimed |
| CN-1174955-C | 3-amino-2-benzyl-1-phenyl-propane derivs. | — | 2004-11-10 | — | — | CN | claimed |
| US-6653508-B2 | Use treating various medical conditions, including pain | GRUENENTHAL GMBH (DE) | 2003-11-25 | — | — | US | claimed |
| US-20020161262-A1 | 3-Amino-2-benzyl-1-phenylpropane derivatives | GRUENTENTHAL GMBH (DE) | 2002-10-31 | — | — | US | claimed |
| CN-1373745-A | 3-amino-2-benzyl-1-phenyl-propane derivs. | GREULENTHAL GMBH (DE) | 2002-10-09 | — | — | CN | claimed |
| EP-0752984-B1 | PROCESS FOR THE PREPARATION OF CYCLOHEXYL-AZETIDINONES | GLAXO WELLCOME SPA (IT) | 1999-05-19 | — | — | EP | claimed |
| US-5817806-A | Process for the preparation of cyclohexyl-azetidinones | GLAXO WELLCOME SPA (IT) | 1998-10-06 | — | — | US | claimed |
| EP-0752984-A1 | PROCESS FOR THE PREPARATION OF CYCLOHEXYL-AZETIDINONES | GLAXO WELLCOME S.p.A. (IT) | 1997-01-15 | — | — | EP | claimed |
| WO-1995026333-A1 | PROCESS FOR THE PREPARATION OF CYCLOHEXYL-AZETIDINONES | GLAXO WELLCOME S.P.A. (IT) | 1995-10-05 | — | — | WO | claimed |
| EP-0383089-B1 | Cold curing reactive resin blend and its use | BAYER AG (DE) | 1994-04-06 | — | — | EP | claimed |
| US-5084544-A | Reaction of polyepoxides and polyisocyanates to form polyurethanes | BAYER AKTIENGESELLSCHAFT (DE) | 1992-01-28 | — | — | US | claimed |
| EP-0383089-A2 | Cold curing reactive resin blend and its use | BAYER AG (DE) | 1990-08-22 | — | — | EP | claimed |
| US-20250263530-A1 | HFCO-CONTAINING ISOCYANATE-REACTIVE COMPOSITIONS, POLYURETHANE FOAMS FORMED THEREFROM, AND COMPOSITE ARTICLES INCLUDING SUCH FOAMS | COVESTRO LLC | 2025-08-21 | — | — | US | disclosed |
| EP-0206621-A1 | Process for disproportionating silanes | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1986-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020161262-A1 | 3-Amino-2-benzyl-1-phenylpropane derivatives | PYGL, CYP11B2, GOT2 | EPHX1 2645/4885TAAR1 3043/4885SLC6A2 690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.